Cian Healthcare Limited (BOM:542678)
22.62
+0.44 (1.98%)
At close: Sep 25, 2026
Cian Healthcare Revenue
In the fiscal year ending March 31, 2026, Cian Healthcare had annual revenue of 282.99M INR, down -8.28%. Cian Healthcare had revenue of 169.77M in the half year ending March 31, 2026, a decrease of -42.02%.
Revenue
282.99M
Revenue Growth
-8.28%
P/S Ratio
2.00
Revenue / Employee
1.66M
Employees
170
Market Cap
565.50M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 282.99M | -25.55M | -8.28% |
| Mar 31, 2025 | 308.54M | -310.38M | -50.15% |
| Mar 31, 2024 | 618.92M | -67.84M | -9.88% |
| Mar 31, 2023 | 686.76M | -93.90M | -12.03% |
| Mar 31, 2022 | 780.66M | 41.25M | 5.58% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Mangalam Drugs & Organics | 2.32B |
| Rajnish Wellness | 1.68B |
| ANG Lifesciences India | 835.87M |
| Source Natural Foods and Herbal Supplements | 796.24M |
| Shelter Pharma | 731.34M |
| Onyx Biotec | 694.69M |
| Panjon | 492.78M |
| Phaarmasia | 486.17M |